Ibutilide - Corvert

Ibutilide, marketed under the brand name Corvert, is a medication primarily used in the medical field to address certain types of irregular heartbeats, specifically atrial fibrillation and atrial flutter. These conditions are characterized by rapid and irregular beating of the atria, the upper chambers of the heart, which can lead to inefficient blood flow and increase the risk of stroke. Ibutilide is classified as a class III antiarrhythmic agent, which means it works by affecting the electrical activity of the heart to restore a normal rhythm.

Mechanism of Action

Ibutilide functions by prolonging the action potential duration and refractory period of cardiac tissue. It achieves this by enhancing the slow inward sodium current and inhibiting the rapid component of the delayed rectifier potassium current. This dual action helps to stabilize the cardiac rhythm by preventing premature electrical impulses that can lead to arrhythmias. By prolonging the refractory period, ibutilide allows the heart to reset its electrical activity, thereby facilitating the conversion of atrial fibrillation or flutter to a normal sinus rhythm.

Indications and Usage

Ibutilide is specifically indicated for the acute termination of recent-onset atrial fibrillation and atrial flutter. It is administered intravenously, making it suitable for use in a hospital setting where patients can be closely monitored. The drug is particularly effective in cases where the arrhythmia has been present for less than 90 days. It is important to note that ibutilide is not used for chronic management of arrhythmias but rather for acute conversion to sinus rhythm.

Administration and Dosage

The administration of ibutilide is typically done under strict medical supervision due to the potential for serious side effects. The standard dosage involves an intravenous infusion over a period of 10 minutes. The dose may be repeated if the initial administration does not result in conversion to sinus rhythm, but this is contingent upon the patient's response and tolerance to the drug. Continuous monitoring of the patient's cardiac rhythm and vital signs is essential during and after the administration of ibutilide.

Side Effects and Precautions

While ibutilide can be effective in restoring normal heart rhythm, it is associated with several potential side effects. The most significant risk is the development of a new arrhythmia, particularly Torsades de Pointes, a type of life-threatening ventricular tachycardia. Other side effects may include hypotension, headache, and nausea. Due to these risks, ibutilide should be used with caution in patients with a history of heart failure, electrolyte imbalances, or prolonged QT interval.

Before administering ibutilide, healthcare providers should ensure that the patient's electrolyte levels, particularly potassium and magnesium, are within normal ranges. Additionally, patients should be screened for any contraindications, such as hypersensitivity to the drug or pre-existing conditions that may exacerbate the risk of adverse effects.

Drug Interactions

Ibutilide can interact with other medications, which may increase the risk of arrhythmias or other side effects. Drugs that prolong the QT interval, such as certain antipsychotics, antidepressants, and other antiarrhythmic agents, should be used with caution in conjunction with ibutilide. It is crucial for healthcare providers to review the patient's medication history and adjust treatment plans accordingly to minimize the risk of interactions.